Exscientia (EXAI) Details Pipeline Prioritisation Strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Exscientia Details Pipeline Prioritisation Strategy
October 3, 2023 8:00 AM EDTConcentrating rapidly emerging pipeline on most differentiated, highest value oncology targets, including CDK7 and LSD1 programmes
Partnering or discontinuing internal development of programmes outside of core focus, including A2A and select discovery targets
Strategy will support continued investment into market-leading technology while maintaining cash runway well into 2026
Partnered pipeline continues to progress with achievement of first milestone for Sanofi collaboration and new collaboration with Merck KGaA
OXFORD, U.K.--(BUSINESS WIRE)-- Exscientia plc (Nasdaq:... More
